Ostentus Therapeutics, Inc announced it raised $520,000 in an initial filing from an offering of $770,000
Ostentus Therapeutics, Inc announced it raised $520,000 in an initial filing from an offering of $770,000
10/13/22, 10:04 AM
Location
newport coast
Money raised
$520,000
Industry
healthcare
Round Type
seed
Company Info
Location
newport center drive
newport coast, california, united states
Additional Info
Ostentus Therapeutics, Inc. is a pre-clinical biotechnology company investigating the activity, efficacy, and safety of its novel natural compounds in the treatment of different types of cancer and leukemia.
Ostentus Therapeutics’ mission is to advance the study and development of its multicancer fighting natural compounds and demonstrate their superior efficacy and safety in humans, through rigorous pharmacological testing.
Currently available options for cancer treatment involve surgical removal and radiation treatment followed by systemic chemotherapy treatment. The primarily available chemotherapeutic agents are antimetabolites (e.g., methotrexate), DNA-interactive agents (e.g., cisplatin, doxorubicin), anti-tubulin agents (e.g., taxanes), hormones, molecular targeting agents and immunotherapeutics.